Clinical trial · Observational
Cancer Sensing: Evaluation of Odour Sampling Techniques
Cancer Sensing: Evaluation of Odour Sampling Techniques to Support the Non-invasive Early Detection of Skin Cancer - Proof of Concept
NCT04206995CI-TRIAL-00055818completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate the suitability of two odour capturing techniques for early detection of skin cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Absorptive patch | Other | — | UNRESOLVED |
| Solid Phase Microextraction (SPME) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Evaluation of odour capturing techniques
- description
- To evaluate two odour capturing techniques to compare VOC profiles of cancerous and healthy skin cancer.
- interventionNames
- Other: Solid Phase Microextraction (SPME)
- Other: Absorptive patch
Primary outcomes (2)
- measure
- Evaluate the suitability of the adsorptive patch for collecting VOCs for analysis for early identification of skin cancer.
- timeFrame
- 30 minutes
- description
- An adsorptive patch, covering skin cancer and healthy skin sites will be applied for a period of maximum 30 minutes to capture VOCs. No drug will be used. This is to investigate the capability of the technique in capturing VOCs.VOCs for analysis for early identification of skin cancer.
- measure
- Evaluate the suitability of the Solid Phase Microextraction (SPME) for analysis for early identification of skin cancer.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with skin cancer, able to speak and understand written English, * 18 years or older and * Capable of giving informed consent. Exclusion Criteria: * Patients too weak to speak or give written informed consent; * Non-English speaking without an interpreter; * Patients lacking mental capacity to consent, or * Below the age of 18.
References
Publications (0)
Data not yet available
No reference posted for this study.